Loading insider details...
Beta
Latest Form 4 (Aug 18, 2026): Grant/Award of 60,492 TRAX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 18, 2026 | First Tracks Biotherapeutics, Inc. (TRAX) | Grant/Award | 60,492 | n/a |
| Aug 7, 2026 | ANAPTYSBIO, INC (ANAB) | Grant/Award | 16,667 | n/a |
| Aug 5, 2026 | First Tracks Biotherapeutics, Inc. (TRAX) | Grant/Award | 60,492 | n/a |
| May 14, 2026 | First Tracks Biotherapeutics, Inc. (TRAX) | Grant/Award | 26,700 | n/a |
| Apr 22, 2026 | First Tracks Biotherapeutics, Inc. (TRAX) | Grant/Award | 83,500 | n/a |
| Jan 10, 2026 | ANAPTYSBIO, INC (ANAB) | Exercise/Conversion | 8,525 | n/a |
| Jan 8, 2026 | ANAPTYSBIO, INC (ANAB) | Exercise/Conversion | 6,145 | n/a |
| Jan 7, 2026 | ANAPTYSBIO, INC (ANAB) | Exercise/Conversion | 10,555 | n/a |
| Dec 23, 2025 | ANAPTYSBIO, INC (ANAB) | Exercise/Conversion | 1,500 | $27.8K |
| Jan 7, 2025 | ANAPTYSBIO, INC (ANAB) | Exercise/Conversion | 10,555 | n/a |